MedPath

Low Frequency Subthalamic Nucleus Deep Brain Stimulation to Improve Verbal Fluency

Not Applicable
Completed
Conditions
Parkinson Disease
Interventions
Device: STN DBS off
Device: STN DBS 130Hz
Device: STN DBS 10Hz
Registration Number
NCT04383665
Lead Sponsor
University of Southern California
Brief Summary

Rationale: Parkinson's disease patients with deep brain stimulation electrodes represent a unique opportunity to study the influence of basal ganglia on neurocognitive function.

Intervention: Patients' deep brain stimulators will be turned off or on and the frequency will be changed to either theta or gamma.

Objectives: To identify differences in higher cognitive functions with stimulation "on" and "off" and theta versus gamma frequency stimulation.

Study population: 12 patients who had previously undergone bilateral STN deep brain stimulation implantation.

Study methodology: Patients will undergo four sessions of neuropsychological testing (RNGT, verbal fluency, D-KEFS CWIT) at baseline, no stimulation, theta stimulation and gamma stimulation, in random order over one day.

Study outcomes: Test results of RNGT, verbal fluency, D-KEFS CWIT. Follow-up: none

Statistics: Test results will be analyzed using within-subjects statistical tests.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  1. Male or female patients who had previously undergone bilateral STN deep brain stimulation implantation
  2. Age >18 years old
  3. Stable medication regimen for at least 3 months.
  4. Patient informed and able to give written consent
  5. Able to comply with all testing, follow-ups and study appointments and protocols
Exclusion Criteria
  1. History of epilepsy or seizure
  2. History of major substance abuse
  3. Patients with baseline settings at less than 1.5 V will be excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
STN DBS offSTN DBS off-
STN DBS 130HzSTN DBS 130Hz-
STN DBS 10HzSTN DBS 10Hz-
Primary Outcome Measures
NameTimeMethod
Delis-Kaplan Executive Function System Verbal Fluency5-15 minutes following stimulation frequency setting change.

Number of words per category in one minute

Delis-Kaplan Executive Function System Color Word Interference Task5-15 minutes following stimulation frequency setting change.

Time to completion of a color-word interference task

Random Number Generation5-15 minutes following stimulation frequency setting change.

Listing of 100 numbers at 1 Hz in a random order.

Evan's RNG: a measure of disproportion with which one number follows another in a sequence. Scores range from 0 (equal proportion of sequence pairs) to 1 (maximum disproportion of sequence pairs). A higher score indicates a lower randomness and poorer exective function.

Count score 1: a measure of propensity to count in steps of 1. The length of each sequence with steps of 1 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 1) to 100000 (all sequences with steps of 1). A higher score indicates lower randomness and poorer exective function.

Count score 2: a measure of propensity to count in steps of 2. The length of each sequence with steps of 2 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 2) to 100000 (all sequences with steps of 2). A higher score indicates lower randomness and poorer exective function.

Evan's RNG, count score 1 and cou

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Keck hospital of the University of Southern California

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath